EJP PHARMACEUTICAL ApS: Financial statements 2025
CVR: 87923614
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
EJP PHARMACEUTICAL ApS (CVR 87923614) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -28,266 and a net result of DKK 214,282 compared with DKK 414,071 the year before. Equity in the 2025 report amounted to DKK 814,282. The solvency ratio was 90.9%.
- Gross Profit
- DKK -28,266
- Profit/Loss
- DKK 214,282
- Equity
- DKK 814,282
- Total Assets
- DKK 895,673
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -28 t. | 214 t. | 814 t. | 0 |
| 2024 | - | -33 t. | 414 t. | 4.4 mio. | 1 |
| 2023 | - | -34 t. | 454 t. | 4.1 mio. | 1 |
| 2022 | - | -49 t. | -478 t. | 6.7 mio. | 1 |
| 2021 | - | -40 t. | 443 t. | 7.3 mio. | 1 |
How creditworthy is EJP PHARMACEUTICAL ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
EJP PHARMACEUTICAL ApS has published its annual report for 2024. Gross profit came to DKK -32,946, and the net result was DKK 414,071.
About EJP PHARMACEUTICAL ApS
EJP PHARMACEUTICAL ApS is a Danish company of the type Anpartsselskab based in Skodsborg, founded in 1982. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Ejvind Jersie Pedersen. The company is owned by Ejvind Jersie Pedersen. The company has 1 employee (2006). In 2025, the company reported a gross profit of DKK -28,266 and a net result of DKK 214,282 compared with DKK 414,071 the year before. Equity in the 2025 report amounted to DKK 814,282.